Pompe Disease Market 2016 to grow at a CAGR of 11.79% during the period to 2020

Pompe disease is a type of LSD. LSD refers to a group of diseases arising from the accumulation of specific substrates. LSDs are progressive and have variable age of onset and clinical symptoms. LSDs are inherited autosomal recessive disorders. Pompe disease has two broad sub-types: infantile-onset Pompe disease and adult-onset Pompe disease. Pompe disease occurs as a result of mutations in the GAA gene. These mutations are responsible for the preventing the action of the enzyme acid alpha-glucosidase, which is responsible for catabolizing glycogen, thereby allowing sugar to accumulate and reach toxic levels in the lysosomes of cells. The buildup of glycogen in certain organs and tissues, mostly in the muscles, hinders the normal functions of organs. Pompe disease is an autosomal recessive disease.

Global Pompe Disease market to grow at a CAGR of 11.79% over the period 2014-2019.

This implies that both the parents pass on one abnormally mutated copy of the gene to their child. A parent carrying an abnormal copy of the gene is known as a carrier. Pompe disease affects both men and women, irrespective of the gender. Pompe disease affects people across all ethnicities and races. Individuals affected with Pompe disease acquire the disease at birth, however, the onset of symptoms varies extensively. More than 300 genetic mutations that can cause Pompe disease have been identified by the researchers till date. Though there is no cure for Pompe disease, diet therapy and enzyme replacement therapy are effective in reducing the clinical manifestations of the disease.

Request For Free Report Sample @ http://goo.gl/t6XJn7

Covered in this Report

This report covers present scenario and the growth prospects of the Global Pompe Disease market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of drugs available in the market for the management of Pompe disease.

The report also presents vendor landscape and a corresponding detailed analysis of the major vendors in the Global Pompe Disease market. The report also considers the revenue that is likely to be generated from the drug candidates that are under various phases of development. In addition, it discusses the major drivers that influence the growth of the market, the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.

The report, Global Pompe Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pompe Disease market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Enquiry About This Report @ http://goo.gl/Lg8Z7s

Key Regions

Americas
APAC
EMEA

Key Vendors

Amicus Therapeutics
BioMarin Pharmaceutical
Genzyme

Other Prominent Vendors

Audentes Therapeutics
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics

Read More Research with TOC @ http://goo.gl/LGlIHD

About PR Market Web

PR Market Web will provide you real and current information related different news. It may be local, national and global news. Also it serves educational guidance to students and market policies to businessmen. So it’s best platform to search any type of news.

Our team has taken efforts in providing high quality services. Visitors can interact directly to our team for any queries and suggestions. This platform is mobile friendly, so you can search for news anytime and anywhere.

Contact US:

Joel John
Suite #8138, 3422 SW 15 Street,
Deerfield Beach, Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Website: http://www.prmarketweb.com/
Email: info@prmarketweb.com

This release was published on openPR.